Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis

BRCA1 interacting helicase 1 (BRIP1) alteration was crucial in tumors and it was a potential therapeutic target in ovarian serous cystadenocarcinoma (OV). Although a small number of studies had focused on BRIP1, an extensive study of BRIP1 genetic mutation and its clinical application in different c...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Guo, Hu, Kuan, Zhang, Xiaofang, Zhou, Ledu, Li, Juanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023799/
https://www.ncbi.nlm.nih.gov/pubmed/36932143
http://dx.doi.org/10.1038/s41598-023-31109-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023799/
https://www.ncbi.nlm.nih.gov/pubmed/36932143
http://dx.doi.org/10.1038/s41598-023-31109-6

Ejemplares similares